PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 17693006-2 2007 Studies have shown that the brain N-acetyl aspartate (NAA) levels are greatly decreased in aralar-deficient mice, suggesting that aralar plays an important role in the synthesis of NAA in neuronal cells. N-acetylaspartate 34-52 solute carrier family 25 member 12 Homo sapiens 91-97 17693006-2 2007 Studies have shown that the brain N-acetyl aspartate (NAA) levels are greatly decreased in aralar-deficient mice, suggesting that aralar plays an important role in the synthesis of NAA in neuronal cells. N-acetylaspartate 54-57 solute carrier family 25 member 12 Homo sapiens 91-97 17693006-2 2007 Studies have shown that the brain N-acetyl aspartate (NAA) levels are greatly decreased in aralar-deficient mice, suggesting that aralar plays an important role in the synthesis of NAA in neuronal cells. N-acetylaspartate 181-184 solute carrier family 25 member 12 Homo sapiens 91-97 17693006-3 2007 Since magnetic resonance spectroscopy studies have revealed consistently reduced NAA levels in various brain regions of schizophrenic patients and their unaffected relatives, genes that affect aralar levels or NAA metabolism in the brain may be implicated in the pathogenesis of schizophrenia. N-acetylaspartate 81-84 solute carrier family 25 member 12 Homo sapiens 193-199 17693006-9 2007 Further studies with SLC25A12 variants relating to brain NAA levels in patients with schizophrenia are suggested. N-acetylaspartate 57-60 solute carrier family 25 member 12 Homo sapiens 21-29 24515575-10 2014 One prior reported SLC25A12 mutation caused complete loss of AGC1 activity in a child with epilepsy, hypotonia, hypomyelination, and reduced brain NAA. N-acetylaspartate 147-150 solute carrier family 25 member 12 Homo sapiens 19-27 35008954-2 2022 The deficiency in AGC1/Aralar leads to the human rare disease named "early infantile epileptic encephalopathy 39" (EIEE 39, OMIM # 612949) characterized by epilepsy, hypotonia, arrested psychomotor neurodevelopment, hypo myelination and a drastic drop in brain aspartate (Asp) and N-acetylaspartate (NAA). N-acetylaspartate 281-298 solute carrier family 25 member 12 Homo sapiens 18-22 35008954-2 2022 The deficiency in AGC1/Aralar leads to the human rare disease named "early infantile epileptic encephalopathy 39" (EIEE 39, OMIM # 612949) characterized by epilepsy, hypotonia, arrested psychomotor neurodevelopment, hypo myelination and a drastic drop in brain aspartate (Asp) and N-acetylaspartate (NAA). N-acetylaspartate 281-298 solute carrier family 25 member 12 Homo sapiens 23-29 35008954-2 2022 The deficiency in AGC1/Aralar leads to the human rare disease named "early infantile epileptic encephalopathy 39" (EIEE 39, OMIM # 612949) characterized by epilepsy, hypotonia, arrested psychomotor neurodevelopment, hypo myelination and a drastic drop in brain aspartate (Asp) and N-acetylaspartate (NAA). N-acetylaspartate 300-303 solute carrier family 25 member 12 Homo sapiens 18-22 35008954-2 2022 The deficiency in AGC1/Aralar leads to the human rare disease named "early infantile epileptic encephalopathy 39" (EIEE 39, OMIM # 612949) characterized by epilepsy, hypotonia, arrested psychomotor neurodevelopment, hypo myelination and a drastic drop in brain aspartate (Asp) and N-acetylaspartate (NAA). N-acetylaspartate 300-303 solute carrier family 25 member 12 Homo sapiens 23-29 35008954-5 2022 Herein, we discuss the role of the AGC1/Aralar-MAS pathway in neuronal functions such as Asp and NAA synthesis, lactate use, respiration on glucose, glutamate (Glu) oxidation and other neurometabolic aspects. N-acetylaspartate 97-100 solute carrier family 25 member 12 Homo sapiens 35-39 28235644-0 2017 Down-regulation of the mitochondrial aspartate-glutamate carrier isoform 1 AGC1 inhibits proliferation and N-acetylaspartate synthesis in Neuro2A cells. N-acetylaspartate 107-124 solute carrier family 25 member 12 Homo sapiens 75-79 28235644-3 2017 Defects in the AGC1 gene cause AGC1 deficiency, an infantile encephalopathy with delayed myelination and reduced brain N-acetylaspartate (NAA) levels, the precursor of myelin synthesis in the CNS. N-acetylaspartate 119-136 solute carrier family 25 member 12 Homo sapiens 15-19 28235644-3 2017 Defects in the AGC1 gene cause AGC1 deficiency, an infantile encephalopathy with delayed myelination and reduced brain N-acetylaspartate (NAA) levels, the precursor of myelin synthesis in the CNS. N-acetylaspartate 138-141 solute carrier family 25 member 12 Homo sapiens 15-19 24515575-10 2014 One prior reported SLC25A12 mutation caused complete loss of AGC1 activity in a child with epilepsy, hypotonia, hypomyelination, and reduced brain NAA. N-acetylaspartate 147-150 solute carrier family 25 member 12 Homo sapiens 61-65 24515575-12 2014 SLC25A12 sequencing should be considered in children with infantile epilepsy, congenital hypotonia, global delay, abnormal myelination, and reduced brain NAA. N-acetylaspartate 154-157 solute carrier family 25 member 12 Homo sapiens 0-8